AI assistant
CONMED Corp — Director's Dealing 2021
Nov 2, 2021
31971_dirs_2021-11-02_85ef0c9b-dda3-4fb1-836c-3431bc381b51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-10-29
Reporting Person: Beyer Pat (President Int'l & Global Ortho)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-29 | Common Stock | M | 55300 | $39.87 | Acquired | 63107 | Direct |
| 2021-10-29 | Common Stock | F | 30018 | $144.62 | Disposed | 33089 | Direct |
| 2021-10-29 | Common Stock | S | 2789 | $144.497 | Disposed | 30300 | Direct |
| 2021-10-29 | Common Stock | S | 16904 | $145.307 | Disposed | 13396 | Direct |
| 2021-10-29 | Common Stock | S | 5589 | $146.135 | Disposed | 7807 | Direct |
| 2021-10-29 | Common Stock | M | 50700 | $51.30 | Acquired | 58507 | Direct |
| 2021-10-29 | Common Stock | F | 33253 | $146.28 | Disposed | 25254 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-29 | Options To Purchase Common Stock | $39.87 | M | 55300 | Disposed | 2026-03-01 | Common Stock (55300) | Direct |
| 2021-10-29 | Sars (Stock Appreciation Rights) | $51.30 | M | 50700 | Disposed | 2025-02-27 | Common Stock (50700) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period.